Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for determining the anti-tumor efficacy of monoclonal antibodies

Method for determining the anti-tumor efficacy of monoclonal antibodies

US Patent 9339560 · Granted May 17, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion proteins specific for CD137 and GPC32025
Bispecific antibodies specific for PD1 and TIM32025
Bispecific HER2 antibodies and methods of use2023
Bispecific antibodies specific for PD1 and TIM32021
HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain I2020
Nucleic acid encoding dual Fc antigen binding proteins2020
HER3 antigen binding proteins binding to the beta-hairpin of HER32020
Monovalent antigen binding proteins2020
Bispecific HER2 antibodies and methods of use2020
Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairp2019
Bispecific antibodies specific for PD1 and TIM32019
Anti-HER3 antibodies and uses thereof2019